SCHEMBL31023936

SCHEMBL31023936

CC(C)(C)OC(=O)N1CCC(Nc2cccnc2)CC1

nearest known ligand 0.73

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 7/20 0.65
ALDH1A1 P00352 2/20 0.62
NPC1 O15118 1/20 0.61
MAPT P10636 1/20 0.61
MAPK1 P28482 1/20 0.61
HTT P42858 1/20 0.61
RAB9A P51151 1/20 0.61
L3MBTL1 Q9Y468 1/20 0.61
CCNA2 P20248 1/20 0.60
CDK2 P24941 1/20 0.60
SIGLEC9 Q9Y336 2/20 0.57
KEAP1 Q14145 1/20 0.56
NFE2L2 Q16236 1/20 0.56
EPHX2 P34913 1/20 0.49
PTPN2 P17706 1/20 0.49
PTPN1 P18031 1/20 0.49
PTPN6 P29350 1/20 0.49
DYRK1A Q13627 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1876139 1.00 GPR119 (0.65) GPR119ALDH1A1NPC1MAPTMAPK1
SCHEMBL29485617 0.93 GPR119 (0.59) GPR119ALDH1A1NPC1MAPTMAPK1
SCHEMBL23022528 0.93 GPR119 (0.59) GPR119ALDH1A1NPC1MAPTMAPK1
SCHEMBL29485608 0.93 GPR119 (0.59) GPR119ALDH1A1NPC1MAPTMAPK1
SCHEMBL23022526 0.93 GPR119 (0.59) GPR119ALDH1A1NPC1MAPTMAPK1
SCHEMBL23022524 0.93 GPR119 (0.59) GPR119ALDH1A1NPC1MAPTMAPK1
SCHEMBL22686681 0.86 EPHX2 (0.68) GPR119ALDH1A1NPC1MAPTMAPK1
SCHEMBL3963092 0.85 ALDH1A1 (0.71) GPR119ALDH1A1NPC1MAPTMAPK1
SCHEMBL1879959 0.85 ALDH1A1 (0.64) GPR119ALDH1A1NPC1MAPTMAPK1
SCHEMBL2709640 0.85 ALDH1A1 (0.74) GPR119ALDH1A1NPC1MAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4665718-A1 SMALL MOLECULES AS MONOACYLGLYCEROL LIPASE (MAGL) INHIBITORS, COMPOSITIONS AND USE THEREOF Apogee Pharmaceuticals, Inc. (CA) 2025-12-24 EP disclosed
WO-2024168426-A1 SMALL MOLECULES AS MONOACYLGLYCEROL LIPASE (MAGL) INHIBITORS, COMPOSITIONS AND USE THEREOF APOGEE PHARMACEUTICALS, INC. (CA) 2024-08-22 WO disclosed